Skip to content
Screener

Beta Bionics BBNX Total Current Assets

Total Current Assets at other companies

Insulet logo
InsuletPODD
$1.85B-18.9%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
$804.64M+30.9%
Medtronic logo
MedtronicMDT
$24.79B+4.1%
Embecta Corp. logo
Embecta Corp.EMBC
$705.1M+3.5%
AdaptHealth logo
AdaptHealthAHCO
$687.48M-7.7%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$933.02M-16.9%

Other financials

Income statement

See full
Revenue$32.0M+37.8%
Gross profit$18.9M+51.2%
Operating income-$25.6M-28.7%
Net income-$23.4M-38.7%
EPS (diluted)-$0.53-35.9%

Balance sheet

See full
Cash & equivalents$44.3M+26.4%
Total debt$6.5M-2.6%
Total equity$256.4M-15.0%
Total assets$292.4M-11.4%

Cash flow

See full
Operating cash flow-$14.6M-7.6%
CapEx$1.0M-41.6%
Free cash flow-$15.7M-1.9%

Valuation

See full
Market cap$715.34M+15.1%
Enterprise value$677.53M+14.2%
P/S-2.0×

Profitability

See full
Gross margin58.3%+4.4pp
Operating margin-69.8%-8.0pp
Net margin-61.3%-15.8pp
FCF margin-51.6%-13.4pp

Returns & leverage

See full
Return on equity-26.2%
Debt / equity0.0×
Current ratio8.9×-5.8×

Where this comes from

Reported directly by Beta Bionics in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The source filing: Beta Bionics’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:20 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-323777
Line itemJune 30,2026December 31,2025
Accounts receivable, net18,05317,118
Inventories23,91821,722
Prepaid expenses and other current assets8,4749,840
Total current assets231,034267,905
Property and equipment, net10,7488,600
Operating lease right-of-use asset5,8166,627
Long-term investments44,64845,431
Other long-term assets141180

Item 1. Financial Statements.

FAQ

What is Beta Bionics's total current assets?
Beta Bionics (BBNX) reported total current assets of $231.03M in Q2 2026.
How has Beta Bionics's total current assets changed year-over-year?
Beta Bionics's total current assets decreased by 19.2% year-over-year, from $286.08M to $231.03M.
What is the long-term trend for Beta Bionics's total current assets?
Over 2 years (2023 to 2025), Beta Bionics's total current assets has grown at a 60.8% compound annual growth rate (CAGR), from $103.62M to $267.91M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.

Ask your AI about Beta Bionics's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude